跳至主要内容
临床试验/EUCTR2012-002873-77-NL
EUCTR2012-002873-77-NL进行中(未招募)不适用

The effect of intranasal insulin on development and behaviour of children with Phelan-McDermid syndrome - Intranasal insulin in PMS

niversity Medical Center Groningen, Department of Genetics0 个研究点开始时间: 2012年11月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age between 12 months and 18 years 0 months old at 1-1-2013
  • Proven SHANK3 deletion by array-comparative genomic hybridization (array-CGH)
  • Parents need to speak and understand Dutch
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 20
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • A contra-indication for the use of intranasal application (e.g. anatomical obstruction)
  • Severe perinatal brain damage (e.g. asphyxia, haemorrhage, infection)
  • A metabolic or muscle disease responsible for neurological symptoms, independent of the 22q13 deletion

研究者

发起方
niversity Medical Center Groningen, Department of Genetics

相似试验